These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6795628)

  • 1. Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasma.
    Weinstein M; Chute L; Deykin D
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5137-41. PubMed ID: 6795628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen.
    Weinstein MJ; Fulcher CA; Chute LE; Zimmerman TS
    Blood; 1983 Nov; 62(5):1114-7. PubMed ID: 6414554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of human thrombin to human factor VIII:RAg.
    Hau L; Firkin BG; Howard MA
    Br J Haematol; 1986 Mar; 62(3):479-85. PubMed ID: 3082349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
    Benson RE; Johnson GS; Dodds WJ
    Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified immunoradiometric assay for factor VIII coagulant antigen.
    Thomas KB; Howard MA; Koutts J; Firkin BG
    Br J Haematol; 1982 May; 51(1):47-57. PubMed ID: 6803825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies.
    Furlong RA; Peake IR
    Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.
    Weinstein MJ; Chute LE; Schmitt GW; Hamburger RH; Bauer KA; Troll JH; Janson P; Deykin D
    J Clin Invest; 1985 Oct; 76(4):1406-11. PubMed ID: 3932466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies.
    Reisner HM; Price WA; Blatt PM; Barrow ES; Graham JB
    Blood; 1980 Oct; 56(4):615-19. PubMed ID: 6774789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies.
    Ingerslev J; Stenbjerg S
    Br J Haematol; 1986 Feb; 62(2):325-32. PubMed ID: 3081021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg).
    Dinesen B; Feddersen C
    Thromb Res; 1983 Sep; 31(5):707-18. PubMed ID: 6417826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function of the factor VIII complex studied with an immobilized heteroantisera to VIII:C.
    Cooper HA; Lee D; Lamb MA; Wagner RH
    Br J Haematol; 1980 Jan; 44(1):149-60. PubMed ID: 6769458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of factor VIII 1,689-Cys: a nonfunctional cofactor occurring in a patient with severe hemophilia A.
    O'Brien DP; Tuddenham EG
    Blood; 1989 Jun; 73(8):2117-22. PubMed ID: 2499363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA; Wagner RH
    J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.